retatrutide news recency 3 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Retatrutide Phase 3 Results: TRIUMPH-1

Choosing the right therapy depends on individual health goals, metabolic needs, and safety considerations

Mistake 1: Shaking the vial during reconstitution This is the single most common mistake

Monthly check-ins with your practitioner allow dose optimization and early identification of any concerns, ensuring safe, sustainable progress toward your health goals

Apelin targets gut contraction to control glucose metabolism via the brain

Low magnesium can disrupt normal hair growth patterns, contributing to increased shedding

Some individuals may experience mild to moderate nausea, which typically improves over time as the body adjusts to the medication